News of the WeekSTEM CELLS

CIRM Awards Seek to Move Cell Therapies to the Clinic

+ See all authors and affiliations

Science  06 Nov 2009:
Vol. 326, Issue 5954, pp. 780-781
DOI: 10.1126/science.326_780a

You are currently viewing the summary.

View Full Text

Summary

Five years after it launched, the California Institute for Regenerative Medicine (CIRM) last week awarded its first disease-oriented grants—$230 million to 14 teams—intended to speed stem cell therapies to patients. In seeming contrast to its original mission, only about one-third of the 4-year grants involve research using embryonic stem (ES) cells. The state created CIRM largely to fund ES cell research, which was lagging because of Bush-era restrictions on the controversial technology.